Edwards Lifesciences Cash End of Year Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 133.44  0.23  0.17%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cash End of Year of Edwards Lifesciences Corporation with missing and latest data points interpolated.
Cash End of Year  10 Years Trend  
Increasing
Slightly volatile
 Cash End of Year 
      Timeline 

Edwards Lifesciences Cash End of Year Over Time

2016-12-31  930,100,000 
2017-12-31  930,100,000 
2018-12-31  867,631,579 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  479,617,814
Geometric Mean  388,485,710
Coefficient Of Variation  62.99
Mean Deviation  261,837,309
Median  396,100,000
Standard Deviation  302,123,590
Range  788,300,000
R Value  0.92
R Squared  0.86
Significance  0.000006
Slope  71,755,986

Currently Trending

MSFT   
 NMS 
Purchased over 30 shares of
few hours ago ago
Traded for 92.72
FB   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 176.01
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 10.63